Rokos Capital Management LLP Instil Bio, Inc. Transaction History

Rokos Capital Management LLP

  • $5.96 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$15.31 - $24.63 $45,930 - $73,890
-3,000 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$24.23 - $27.06 $72,690 - $81,180
3,000 New
3,000 $75,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $3.44B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Rokos Capital Management LLP Portfolio

Follow Rokos Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rokos Capital Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email